コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Canadian provinces, specifically for severe traumatic brain injury.
2 y mechanical impact in a mouse model of mild traumatic brain injury.
3 ma are serious complications of ischemic and traumatic brain injury.
4 tical function in patients with acute severe traumatic brain injury.
5 uces an SIR compatible with ischemia or mild traumatic brain injury.
6 11A-31 on learning and memory outcomes after traumatic brain injury.
7 tic role of early MRI in moderate and severe traumatic brain injury.
8 f systolic dysfunction after moderate-severe traumatic brain injury.
9 ty in brains of athletes with sports-related traumatic brain injury.
10 he best outcome predictors for patients with traumatic brain injury.
11 ions about sport-related concussion and mild traumatic brain injury.
12 flammatory cytokine expression in a model of traumatic brain injury.
13 o, we evaluated the outcome in two models of traumatic brain injury.
14 h for preserving neurological function after traumatic brain injury.
15 e compared to controls immediately following traumatic brain injury.
16 d, and there is no efficacious treatment for traumatic brain injury.
17 iscrete phenomenon in the pathophysiology of traumatic brain injury.
18 n in a unique sample of combat veterans with traumatic brain injury.
19 vivo needle prick model to mimic sequelae of traumatic brain injury.
20 teractions between four treatments following traumatic brain injury.
21 and has a beneficial effect on outcome after traumatic brain injury.
22 cohort consisted of 817 subjects with severe traumatic brain injury.
23 Sedated patients with severe traumatic brain injury.
24 e lesions are comparable with impact-induced traumatic brain injury.
25 tic amnesia is very common immediately after traumatic brain injury.
26 rologic disorders as diverse as migraine and traumatic brain injury.
27 ng that axonal integrity is maintained after traumatic brain injury.
28 odel in which pathology arises from a single traumatic brain injury.
29 the subsequent outcome in 2 mouse models of traumatic brain injury.
30 the main causes of ongoing disability after traumatic brain injury.
31 inuous variable (p = 0.07) for patients with traumatic brain injury.
32 terns for discriminating clinical outcome in traumatic brain injury.
33 are still considered the most lethal type of traumatic brain injury.
34 the acute phase following moderate or severe traumatic brain injury.
35 omy for intraocular hemorrhages secondary to traumatic brain injury.
36 rebral edema is a key poor prognosticator in traumatic brain injury.
37 rising from neurodegenerative disease and/or traumatic brain injury.
38 dysfunction in patients with moderate-severe traumatic brain injury.
39 omy for intraocular hemorrhages secondary to traumatic brain injury.
40 ia has been used to attenuate the effects of traumatic brain injuries.
41 s-related concussion and other types of mild traumatic brain injuries.
42 at associated with impact-induced, non-blast traumatic brain injuries.
43 time with brain tissue hypoxia after severe traumatic brain injury (0.45 in intracranial pressure-on
44 , including (1) reducing SICU care for minor traumatic brain injury, (2) optimizing postoperative air
45 lfonylurea receptor-1 was detected in severe traumatic brain injury, absent in controls, correlated w
46 tive diseases and cognitive impairment after traumatic brain injury, all hallmarked by the accumulati
47 luding cases with and without chronic impact traumatic brain injuries and cases with chronic exposure
50 in 32 patients with isolated moderate-severe traumatic brain injury and 32 patients with isolated mil
51 n hospital including 6516 (78%) after severe traumatic brain injury and 749 (9%) after severe thoraco
53 oderated mediation analysis showed that mild traumatic brain injury and high genetic risk indirectly
54 l thickness, such that individuals with mild traumatic brain injury and high genetic risk showed redu
55 ory neurotransmitter systems is common after traumatic brain injury and is an important cause of cogn
56 le in human cerebrospinal fluid after severe traumatic brain injury and is an informative biomarker o
57 its potential to guide targeted therapies in traumatic brain injury and other diseases involving cere
58 ages of 19 and 58, many of whom carried mild traumatic brain injury and post-traumatic stress disorde
59 ed 408 patients, 10 to 65 years of age, with traumatic brain injury and refractory elevated intracran
60 , decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hyper
61 t develops following brain injuries, such as traumatic brain injury and stroke, and is often associat
62 egenerative pathway promotes pathogenesis in traumatic brain injury and suggest that anti-SARM1 thera
63 e oxygenation levels in patients with severe traumatic brain injury and the feasibility of a Phase II
64 n trauma systems, assess the contribution of traumatic brain injury and thoracoabdominal injury to ob
65 iously healthy patients with moderate-severe traumatic brain injury, and it is reversible over the fi
67 us neurological disorders, including stroke, traumatic brain injury, and subarachnoid hemorrhage.
68 omy for intraocular hemorrhages secondary to traumatic brain injury, and the timing of vitrectomy in
69 rtex connectivity in the chronic phase after traumatic brain injury, and this abnormality was also ob
70 the United States over 1.7 million cases of traumatic brain injury are reported yearly, but predicti
71 egates in axons of the corpus callosum after traumatic brain injury as compared to Sarm1(+/+) mice.
72 degeneration, demonstrate multiple improved traumatic brain injury-associated phenotypes after injur
73 tribution of inflammatory conditions such as traumatic brain injury, autoimmune disorders, and infect
75 ) 10 years and older with moderate or severe traumatic brain injury (Barell Matrix Type 1 classificat
76 Treatment of secondary injury after severe traumatic brain injury based on brain tissue oxygenation
78 s have been developed to standardize care in traumatic brain injury, between-center variation in trea
79 brain, has recently been linked to sleep and traumatic brain injury, both of which can affect the pro
81 f the pathophysiology of mild, blast-induced traumatic brain injury (bTBI) the exposure of dissociate
82 s intracranial hypertension in patients with traumatic brain injury but was associated with harm in t
88 in injury and 32 patients with isolated mild traumatic brain injury (comparison group) was assessed w
90 e classified into post-traumatic amnesia and traumatic brain injury control groups, based on their pe
91 -channel head coil from each of 3 concussive traumatic brain injury (cTBI) patients and 4 controls tw
94 her neurologic conditions, including stroke, traumatic brain injury, encephalopathy, and dementia.
96 ction with previous studies with axotomy and traumatic brain injury, establish SARM1 as the central d
97 ast exposure, five cases with chronic impact traumatic brain injury, five cases with exposure to opia
100 ssment included history of playing rugby and traumatic brain injury, general and mental health, life
101 nsecutive children (age < 18 yr) with severe traumatic brain injury (Glasgow Coma Scale </= 8; intrac
105 xygenation and poor outcome following severe traumatic brain injury has been reported in observationa
106 n injury, or to a single, moderate or severe traumatic brain injury, has led to an awareness that it
107 lecular pathways underlying the pathology of traumatic brain injury have not been defined, and there
110 rognosis and Analysis of Clinical Trials in [Traumatic Brain Injury] (IMPACT) extended model sum scor
111 quantify benefits of hypothermia therapy for traumatic brain injuries in adults and children by analy
112 a is likely a beneficial treatment following traumatic brain injuries in adults but cannot be recomme
115 his platform to study metabolic responses to traumatic brain injury in hippocampal slice cultures, an
117 sive care who had suffered a primary, closed traumatic brain injury; increased intracranial pressure;
119 miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation an
120 ls with intraocular hemorrhages secondary to traumatic brain injury, irrespective of the timing of vi
123 impact (CCI) procedure in rats, we show that traumatic brain injury is associated with an increase in
124 These results provide evidence that mild traumatic brain injury is associated with greater neurod
129 nogenesis, stroke, intracerebral hemorrhage, traumatic brain injury, ischemia-reperfusion injury, and
130 is the first-line imaging technique for all traumatic brain injury, it is incapable of providing lon
133 ity in the neuromonitoring setting of severe traumatic brain injury may carry novel pathophysiologica
136 lgals-1(-/-) mice to develop spinal cord- or traumatic brain injury models for the evaluation of the
139 appropriate treatment of children with mild traumatic brain injury (mTBI) and intracranial injury (I
140 Evidence is accumulating that repeated mild traumatic brain injury (mTBI) incidents can lead to pers
143 it remains unknown the extent to which mild traumatic brain injury (mTBI) may impact these critical
144 ) as a diagnostic tool in patients with mild traumatic brain injury (mTBI) with posttraumatic migrain
147 y of the neurodegeneration that occurs after traumatic brain injury, now termed chronic traumatic enc
148 l/glial DNA was identified in patients after traumatic brain injury or cardiac arrest; and exocrine p
149 olarization in the cerebral cortex following traumatic brain injury or cerebral ischemia, significant
152 disease, although it is unclear whether mild traumatic brain injury, or concussion, also confers risk
153 nboxers who were exposed to repetitive, mild traumatic brain injury, or to a single, moderate or seve
155 nces (P < 0.0001); 11.1% to 26.0% for severe traumatic brain injury (P < 0.0001), and 4.7% to 5.9% fo
156 troke, AD, age-related macular degeneration, traumatic brain injury, Parkinson's disease, and other n
157 directed treatment of most blast-associated traumatic brain injuries, partly because the underlying
158 nylurea receptor-1 was present in all severe traumatic brain injury patients (mean = 3.54 +/- 3.39 ng
161 The adult validation cohort comprised recent traumatic brain injury patients from San Gerardo Hospita
162 evere traumatic brain injury and 0 (0%) mild traumatic brain injury patients had systolic dysfunction
163 isodes of increased intracranial pressure in traumatic brain injury patients has been previously deve
164 nsor imaging abnormalities in a cohort of 97 traumatic brain injury patients were also mapped at the
165 rough standard behavioral assessments in 181 traumatic brain injury patients who had lost the ability
173 activation occurs after single and repeated traumatic brain injury, possibly through sports-related
175 neuropathology; ibuprofen was preferred for traumatic brain injury, postcraniotomy, and thromboembol
176 ribed glymphatic system has been linked with traumatic brain injury, prolonged wakefulness, and aging
178 tial Glasgow Coma Scale score for predicting traumatic brain injury recovery, but it takes days/weeks
179 mant as posttraumatic amnesia for predicting traumatic brain injury recovery, introducing a new varia
181 nsecutive patients undergoing CT imaging for traumatic brain injury recruited between January and Oct
183 vidence that memory impairment acutely after traumatic brain injury results from altered parahippocam
186 duals experience a single moderate to severe traumatic brain injury suggest widespread persistent mic
189 the blood-brain barrier (BBB) in response to traumatic brain injury (TBI) allows for the accumulation
190 is an important pathoanatomical subgroup of traumatic brain injury (TBI) and a major driver of morta
192 with cognitive fatigue between persons with traumatic brain injury (TBI) and healthy controls (HCs).
194 after injury and determine the influence of traumatic brain injury (TBI) and massive transfusion on
197 ually, there are over 2 million incidents of traumatic brain injury (TBI) and treatment options are n
198 f veterans who sustained combat-related mild traumatic brain injury (TBI) are associated with scalar
206 on individuals living with disabilities from traumatic brain injury (TBI) in the United States, and 8
224 etrospectively examined whether a history of traumatic brain injury (TBI) is associated with an earli
232 ry deficits after TBI.SIGNIFICANCE STATEMENT Traumatic brain injury (TBI) is the leading cause of dea
233 ession involved in the MQC in rats receiving traumatic brain injury (TBI) of different severities.
235 sregulation of pathways directly involved in traumatic brain injury (TBI) pathogenesis and have been
237 etection of neuron-specific enolase (NSE), a traumatic brain injury (TBI) protein biomarker, in dilut
244 ipoprotein E4 (ApoE4) genotype combines with traumatic brain injury (TBI) to increase the risk of dev
245 major role in the etiology of mouse model of traumatic brain injury (TBI), a condition associated wit
248 usly been shown to occur in animal models of traumatic brain injury (TBI), and blocking this form of
250 eater risk of Parkinson's disease (PD) after traumatic brain injury (TBI), but it is possible that th
251 g is a mainstay of therapy for children with traumatic brain injury (TBI), but its overall associatio
252 tive disease, cerebral ischemia (stroke) and traumatic brain injury (TBI), drives spreading neurotoxi
254 PSH has predominantly been described after traumatic brain injury (TBI), in which it is associated
257 ngth and learning, is dysregulated following traumatic brain injury (TBI), suggesting that stimulatio
259 trocytes to fluid shear stress in a model of traumatic brain injury (TBI), we found that shear stress
280 ecific outcome measure (clinically important traumatic brain injury [TBI], need for neurological inte
282 The long-term clinical effects of wartime traumatic brain injuries (TBIs), most of which are mild,
283 s led to an awareness that it is exposure to traumatic brain injury that carries with it a risk of th
284 dary events triggered by blast-induced, mild traumatic brain injury that is commonly observed in mili
285 ion and those affected by various degrees of traumatic brain injury), the identification of reliable
287 creasingly used in the early phase following traumatic brain injury, the prognostic utility of MRI re
288 functionality essential to the treatment of traumatic brain injury; the measurement performance of o
289 microglia in models of stroke, infection and traumatic brain injury, though the exact role of the imm
290 to the intensive care unit for acute severe traumatic brain injury to test two hypotheses: (i) in pa
291 nd over the first week after moderate-severe traumatic brain injury; transthoracic echocardiogram wit
292 Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial-a comparative effectiveness
293 improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been ex
294 series, we investigated several features of traumatic brain injuries, using clinical histopathology
296 y or Glasgow Outcome Scale for patients with traumatic brain injury were the pressure reactivity inde
297 of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been
298 lthy civilians, and from civilians with mild traumatic brain injury, which is commonly comorbid with
299 tion that can decrease ischemic injury after traumatic brain injury without increasing bleeding tende
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。